These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 2142344

  • 1. Evidence that monoclonal antibodies against the 55kD subunit of the rat IL-2 receptor do not inhibit the development of suppressor cells generated in mixed lymphocyte culture.
    Tanaka K, Turka LA, Kupiec-Weglinski JW, Milford EL, Ueda H, Diamantstein T, Carpenter CB, Tilney NL.
    Transplantation; 1990 Jul; 50(1):125-31. PubMed ID: 2142344
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
    Tanaka K, Hancock WW, Osawa H, Stunkel KG, Alberghini TV, Diamantstein T, Tilney NL, Kupiec-Weglinski JW.
    J Immunol; 1989 Nov 01; 143(9):2873-9. PubMed ID: 2530281
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Agonistic and antagonistic interactions of anti-interleukin 2 receptor monoclonal antibodies in rat recipients of cardiac allografts.
    Kupiec-Weglinski JW, Tilney NL, Stunkel KG, Grutzmann R, van der Meide PH, Di Stefano R, Diamantstein T.
    Transplantation; 1989 Jan 01; 47(1):11-6. PubMed ID: 2463699
    [Abstract] [Full Text] [Related]

  • 6. Biodistribution of anti-interleukin 2 receptor monoclonal antibodies correlates with their therapeutic efficacy following transplantation.
    Kupiec-Weglinski JW, Mariani G, Tanaka K, Di Stefano R, Stünkel KG, Diamantstein T, Tilney NL.
    Cell Immunol; 1989 Oct 01; 123(1):148-57. PubMed ID: 2476241
    [Abstract] [Full Text] [Related]

  • 7. Development of suppressor lymphocytes during acute rejection of rat cardiac allografts and preservation of suppression by anti-IL-2-receptor monoclonal antibody.
    Schneider TM, Kupiec-Weglinski JW, Towpik E, Padberg W, Araneda D, Diamantstein T, Strom TB, Tilney NL.
    Transplantation; 1986 Aug 01; 42(2):191-6. PubMed ID: 2943063
    [Abstract] [Full Text] [Related]

  • 8. Anti-interleukin 2 receptor monoclonal antibodies spare phenotypically distinct T suppressor cells in vivo and exert synergistic biological effects.
    Di Stefano R, Mouzaki A, Araneda D, Diamantstein T, Tilney NL, Kupiec-Weglinski JW.
    J Exp Med; 1988 Jun 01; 167(6):1981-6. PubMed ID: 2968435
    [Abstract] [Full Text] [Related]

  • 9. Direct evidence of a functional separation of alloreactive T lymphocytes from bystander cells infiltrating rat allografts. Interleukin 2 receptor-positive cells reacting with the monoclonal antibody ART 18 mediating second-set rejection.
    Heidecke CD, Brauer R, Schneider-Eicke J, Schilling T, Wolff S, Diamantstein T.
    Transplantation; 1990 Jul 01; 50(1):101-6. PubMed ID: 2368130
    [Abstract] [Full Text] [Related]

  • 10. Effects of interleukin 2 receptor b chain (P75)-specific monoclonal antibody on the generation of cytotoxic T lymphocytes and suppressor T cells in mixed lymphocyte culture.
    Kusaka S, Sakagami K, Fujiwara T, Uda M, Orita K.
    Transpl Int; 1992 Jul 01; 5 Suppl 1():S698-702. PubMed ID: 14621914
    [Abstract] [Full Text] [Related]

  • 11. The mechanism of synergistic interaction between anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy in rat recipients of organ allografts.
    Ueda H, Hancock WW, Cheung YC, Diamantstein T, Tilney NL, Kupiec-Weglinski JW.
    Transplantation; 1990 Oct 01; 50(4):545-50. PubMed ID: 2219270
    [Abstract] [Full Text] [Related]

  • 12. Suppressor cells and T cell synergy in the primary MLR: interleukin-2 is required for the maintenance of rat CD8+ suppressor cells.
    Van Sickler JT, Pickard LL, Salomon DR.
    Cell Immunol; 1991 May 01; 134(2):390-401. PubMed ID: 1708702
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R, Cassatella MA, Trentin L, Bulian P, Siviero F, Feruglio C, Agostini C, Vespignani M, Chisesi T, Pizzolo G.
    Leukemia; 1991 Nov 01; 5(11):942-50. PubMed ID: 1835747
    [Abstract] [Full Text] [Related]

  • 17. Regulation of the immune response to alloantigens: suppressor and helper T cells generated in the primary MLR of the rat.
    Salomon DR, Cohen DJ, Carpenter CB, Milford EL.
    J Immunol; 1983 Sep 01; 131(3):1065-72. PubMed ID: 6193172
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.